Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

Auteurs : De Silva P, Garaud S, Solinas C, de Wind A, Van den Eyden G, Jose V, Gu-Trantien C, Migliori E, Boisson A, Naveaux C, Duvillier H, Craciun L, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Jaar : 2019
Journal : EBioMedicine
Volume : 39
Pagina's : 226-238

BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.

Auteurs : Solinas C, Marcoux D, Garaud S, Vitória JR, Van den Eynden G, de Wind A, De Silva P, Boisson A, Craciun L, Larsimont D, Piccart-Gebhart M, Detours V, Tkint de Roodenbeke D, Willard-Gallo K
Jaar : 2019
Journal : Cancer Lett
Volume : 450
Pagina's : 88-97

ESR1 mutations in metastatic lobular breast cancer patients.

Auteurs : Desmedt C, Pingitore J, Rothé F, Marchio C, Clatot F, Rouas G, Richard F, Bertucci F, Mariani O, Galant C, Fribbens C, OLeary B, Van den Eynden G, Salgado R, Turner NC, Piccart-Gebhart M, Vincent-Salomon A, Pruneri G, Larsimont D, Sotiriou C
Jaar : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pagina's : 9

Genomic, transcriptomic, epigenetic, and immune profiling of mucinous breast cancer.

Auteurs : Nguyen B, Veys I, Leduc S, Bareche Y, Majjaj S, Brown DN, Boeckx B, Sotiriou C, Larsimont D, Desmedt C
Jaar : 2019
Journal : J Natl Cancer Inst

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.

Auteurs : Bonnefoi H, Macgrogan G, Poncet C, Iggo R, Pommeret F, Grellety T, Larsimont D, Bécette V, Kerdraon O, Bibeau F, Ghnassia JP, Picquenot JM, Thomas J, Tille JC, Slaets L, Bodmer A, Bergh J, Cameron D
Jaar : 2019
Journal : Br J Cancer

Reprogramming of energetic metabolism: increased expression and roles of pyruvate carboxylase in papillary thyroid cancer.

Auteurs : Strickaert A, Corbet C, Spinette SA, Craciun L, Dom G, Andry G, Larsimont D, Wattiez R, Dumont JE, Feron O, Maenhaut C
Jaar : 2019
Journal : Thyroid

ICG-fluorescence imaging for detection of peritoneal metastases and residual tumoral scars in locally advanced ovarian cancer: A pilot study.

Auteurs : Veys I, Pop FC, Vankerckhove S, Barbieux R, Chintinne M, Moreau M, Nogaret JM, Larsimont D, Donckier V, Bourgeois P, Liberale G
Jaar : 2018
Journal : J Surg Oncol
Volume : 117(2)
Pagina's : 228-235

Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature.

Auteurs : Philippe A, Rassy M, Craciun L, Naveaux C, Willard-Gallo K, Larsimont D, Veys I
Jaar : 2018
Journal : Int J Gynecol Pathol
Volume : 37
Pagina's : 482-487

Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers.

Auteurs : Tarabichi M, Antoniou A, Le Pennec S, Gacquer D, de Saint-Aubain de Somerhausen N, Craciun L, Cielen T, Laios I, Larsimont D, Andry G, Dumont JE, Maenhaut C, Detours V
Jaar : 2018
Journal : J Clin Endocrinol Metab
Volume : 103(3)
Pagina's : 1102-1111

Genomic hotspots but few recurrent fusion genes in breast cancer.

Auteurs : Fimereli D, Fumagalli D, Brown D, Gacquer D, Rothé F, Salgado R, Larsimont D, Sotiriou C, Detours V
Jaar : 2018
Journal : Genes Chromosomes Cancer
Volume : 57(7)
Pagina's : 331-338

Immune Infiltration in Invasive Lobular Breast Cancer.

Auteurs : Desmedt C, Salgado R, Fornili M, Pruneri G, Van den Eynden G, Zoppoli G, Rothé F, Buisseret L, Garaud S, Willard-Gallo K, Brown D, Bareche Y, Rouas G, Galant C, Bertucci F, Loi S, Viale G, Di Leo A, Green AR, Ellis IO, Rakha EA, Larsimont D, Biganzoli E, Sotiriou C
Jaar : 2018
Journal : J Natl Cancer Inst
Volume : 110(7)
Pagina's : 768-776

Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: a TransHERA study.

Auteurs : Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, de Azambuja E, Larsimont D, Rojo F, Viale G, Toi M, Harbeck N, Pritchard KI, Gelber Rd, Dinh P, Zardavas D, Leyland-Jones B, Piccart-Gebhart M, Dowsett M
Jaar : 2018
Journal : Clin Cancer Res
Volume : 24(13)
Pagina's : 3079-3086

ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.

Auteurs : Veys I, Pop CF, Barbieux R, Moreau M, Noterman D, De Neubourg F, Nogaret JM, Liberale G, Larsimont D, Bourgeois P
Jaar : 2018
Journal : PLoS ONE
Volume : 13
Pagina's : e0197857 (13pages)

Retroperitoneal mixed malignant mullerian tumor : exceptional localisation and prognosis.

Auteurs : El Hachem G, Jungels C, Larsimont D, Awada A
Jaar : 2018
Journal : Rev Med Brux
Volume : 39
Pagina's : 146-149

Small cell carcinoma of the endometrium: A clinicopathological study and management of three cases.

Auteurs : Sidibe FM, Traore Z, Georgala A, Kanab R, Larsimont D, Awada A, Piccart-Gebhart M
Jaar : 2018
Journal : Bull Cancer
Volume : 105
Pagina's : 842-846

The impact of breast MRI workup on tumor size assessment and surgical planning in patients with early breast cancer.

Auteurs : Pop CF, Stanciu-Pop C, Drisis S, Radermeker M, Vandemerckt C, Noterman D, Moreau M, Larsimont D, Nogaret JM, Veys I
Jaar : 2018
Journal : Breast J
Volume : 24
Pagina's : 927-933

Ex vivo indocyanine green fluorescence imaging for the detection of lymph node involvement in advanced-stage ovarian cancer.

Auteurs : Pop CF, Veys I, Gomez Galdon M, Moreau M, Larsimont D, Donckier V, Bourgeois P, Liberale G
Jaar : 2018
Journal : J Surg Oncol
Volume : 118(7)
Pagina's : 1163-1169

Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer.

Auteurs : Garaud S, Zayakin P, Buisseret L, Rulle U, Silina K, de Wind A, Van den Eyden G, Larsimont D, Willard-Gallo K
Jaar : 2018
Journal : Front Immunol
Volume : 9
Pagina's : 2660

N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imaging.

Auteurs : Wimana Z, Gebhart G, Guiot T, Vanderlinden B, Larsimont D, Doumont G, Van Simaeys G, Goldman S, Flamen P, Ghanem G
Jaar : 2017
Journal : Oncotarget

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.

Auteurs : Brown D, Smeets D, Székely B, Larsimont D, Szász AM, Adnet PY, Rothé F, Rouas G, Nagy ZI, Faragó Z, Dank M, Szentmártoni G, Udvarhelyi N, Zoppoli G, Pusztai L, Piccart-Gebhart M, Kulka J, Lambrechts D, Sotiriou C, Desmedt C
Jaar : 2017
Journal : Nat Commun
Volume : 8
Pagina's : 14944

Volg ons!

Het onderzoek steunen

Het onderzoek steunen

Het onderzoek aan het Jules Bordet Instituut is afhankelijk van uw gulheid. Doe een gift en neem deel aan de strijd tegen kanker

Meer informatie